Original Literature | Model OverView |
---|---|
Publication
Title
Function of RIG-I-like receptors in antiviral innate immunity.
Affiliation
Laboratory of Molecular Genetics, Institute for Virus Research and GraduateSchool of Biostudies, Kyoto University, Kyoto 606-8507, Japan.
Abstract
PMID
17395582
|
Entity
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
dsRNA: RIG-1
--
e11
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m11
0
infinite
0
--
5'-triphosphate ssRNA
--
e12
cso30:c:Rna
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m12
0
infinite
0
--
5'-triphosphate ssRNA: RIG-1
--
e13
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m13
0
infinite
0
--
poly(rI:rC)
--
e14
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
csml-variable:Double
m14
0
infinite
0
--
poly(rA:rU)
--
e15
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m15
0
infinite
0
--
poly(rI:rC): RIG-1
--
e16
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m16
0
infinite
0
--
poly(rA:rU): RIG-1
--
e17
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m17
0
infinite
0
--
--
e18
cso30:c:EntityBiologicalCompartment
cso30:i:CC_MitochondrialChromosome
--
--
--
csml-variable:Double
m18
0
infinite
0
--
--
e19
cso30:c:EntityBiologicalCompartment
cso30:i:CC_MitochondrialCentromere
--
--
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
--
e20
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Mitochondria
--
--
--
csml-variable:Double
m20
0
infinite
0
--
--
e21
cso30:c:EntityBiologicalCompartment
cso30:i:CC_MitochondrialEnvelope
--
--
--
csml-variable:Double
m21
0
infinite
0
--
--
e22
cso30:c:EntityBiologicalCompartment
cso30:i:CC_MitochondrialLumen
--
--
--
csml-variable:Double
m22
0
infinite
0
--
--
e23
cso30:c:EntityBiologicalCompartment
cso30:i:CC_MitochondrialMatrix
--
--
--
csml-variable:Double
m23
0
infinite
0
--
--
e24
cso30:c:EntityBiologicalCompartment
cso30:i:CC_MitochondrialInnerMembrane
--
--
--
csml-variable:Double
m24
0
infinite
0
--
--
e25
cso30:c:EntityBiologicalCompartment
cso30:i:CC_MitochondrialOuterMembrane
--
--
--
csml-variable:Double
m25
0
infinite
0
--
--
e26
cso30:c:EntityBiologicalCompartment
cso30:i:CC_MitochondrialIntermembraneSpace
--
--
--
csml-variable:Double
m26
0
infinite
0
--
MDA5
--
e27
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
dsRNA: MDA5
--
e28
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m28
0
infinite
0
--
IPS-1
--
e29
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
dsRNA: RIG-1: IPS-1
--
e30
cso30:c:Complex
cso30:i:CC_MitochondrialIntermembraneSpace
--
csml-variable:Double
m30
0
infinite
0
--
ATP
--
e31
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m31
0
infinite
0
--
dsRNA: RIG-1: ATP
--
e32
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m32
0
infinite
0
--
dsRNA: MDA5: IPS-1
--
e33
cso30:c:Complex
cso30:i:CC_MitochondrialIntermembraneSpace
--
csml-variable:Double
m33
0
infinite
0
--
TRAF3
--
e34
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m34
0
infinite
0
--
dsRNA: MDA5: IPS-1: TRAF3
--
e35
cso30:c:Complex
cso30:i:CC_MitochondrialIntermembraneSpace
--
csml-variable:Double
m35
0
infinite
0
--
dsRNA: RIG-1: IPS-1: TRAF3
--
e36
cso30:c:Complex
cso30:i:CC_MitochondrialIntermembraneSpace
--
csml-variable:Double
m36
0
infinite
0
--
IKK-i
--
e37
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m37
0
infinite
0
--
TBK-1
--
e38
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m38
0
infinite
0
--
dsRNA: MDA5: IPS-1: TRAF3: IKK-i: TBK-1
--
e39
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
dsRNA: RIG-1: IPS-1: TRAF3: IKK-i: TBK-1
--
e40
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m40
0
infinite
0
--
IRF-3
--
e41
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m41
0
infinite
0
--
IRF-7
--
e42
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m42
0
infinite
0
--
IRF-3{activated}
--
e43
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m43
0
infinite
0
--
IRF-7{activated}
--
e44
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m44
0
infinite
0
--
IKK complex
--
e45
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m45
0
infinite
0
--
IKK complex{activated}
--
e46
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m46
0
infinite
0
--
NF-kappaB
--
e47
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m47
0
infinite
0
--
NF-kappaB{activated}
--
e48
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m48
0
infinite
0
--
IFN
--
e49
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m49
0
infinite
0
--
RIG-1
--
e5
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
dsRNA
--
e6
cso30:c:RnaOther
cso30:i:CC_Extracellular
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
LGP2
--
e63
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m63
0
infinite
0
--
MyD88
--
e64
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m64
0
infinite
0
--
--
e65
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Endosome
--
--
--
csml-variable:Double
m65
0
infinite
0
--
--
e66
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeLumen
--
--
--
csml-variable:Double
m66
0
infinite
0
--
--
e67
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeMembrane
--
--
--
csml-variable:Double
m67
0
infinite
0
--
ligand: TLR7/TLR8
--
e68
cso30:c:Complex
cso30:i:CC_EndosomeMembrane
--
--
csml-variable:Double
m68
0
infinite
0
--
MyD88{activated}
--
e69
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m69
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
ligand: TLR9
--
e70
cso30:c:Complex
cso30:i:CC_EndosomeMembrane
--
--
csml-variable:Double
m70
0
infinite
0
--
TLR3
--
e71
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m71
0
infinite
0
--
dsRNA: TLR3
--
e72
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m72
0
infinite
0
--
IRAK-1: IRAK4
--
e73
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m73
0
infinite
0
--
IRAK-1: IRAK4{activated}
--
e74
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m74
0
infinite
0
--
TRAF6
--
e75
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m75
0
infinite
0
--
TRAF6{activated}
--
e76
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m76
0
infinite
0
--
TRAF3
--
e77
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m77
0
infinite
0
--
TRAF3{activated}
--
e78
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m78
0
infinite
0
--
IKK-alpha
--
e79
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m79
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
IKK-alpha{activated}
--
e80
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m80
0
infinite
0
--
TRIF
--
e81
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m81
0
infinite
0
--
dsRNA: TLR3: TRIF
--
e82
cso30:c:Complex
cso30:i:CC_EndosomeMembrane
--
csml-variable:Double
m82
0
infinite
0
--
IKK-i: TBK-1
--
e83
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m83
0
infinite
0
--
IKK-i: TBK-1{activated}
--
e84
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m84
0
infinite
0
--
poly(rI:rC): MDA-5
--
e85
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m85
0
infinite
0
--
csml-variable:Double
m86
0
infinite
0
--
IL-12p40
--
e87
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m87
0
infinite
0
--
IL-8
--
e88
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m88
0
infinite
0
--
csml-variable:Double
m89
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
protein remnant
--
e90
cso30:c:EntityBiological
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m90
0
infinite
0
--
NS1
--
e91
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m91
0
infinite
0
--
VP35
--
e92
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m92
0
infinite
0
--
V protein
--
e93
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m93
0
infinite
0
--
p1
p1
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c121 : 1
stoichiometry:c123 : 1
stoichiometry:c6 : 1
m5*m6*0.1
nodelay
--
0
PMID: 17395582 The virus-specific RNA species, dsRNA or 5'-triphosphate ssRNA, specifically binds to RIG-I through its RNA binding domain. PMID: 17395582, 17190814 RNA binding requires intact helicase and C-terminal autorepression domains. PMID: 17395582 Table2
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c28 : 1
stoichiometry:c30 : 1
m34*m30*0.1
nodelay
--
0
PMID: 17395582, 16858409, 15210743, 15210742 The latter involves TNF (tumor necrosis factor) receptor-associating factor 3 (TRAF3) (17) and the protein kinase, I{kappa}B kinase-i (IKK-i ({epsilon})) or TANK-binding kinase-1 (TBK-1) (18, 19), which is responsible for the activation of IRF-3 and -7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c35 : 1
stoichiometry:c33 : 1
stoichiometry:c37 : 1
m37*m38*m35*0.1
nodelay
--
0
PMID: 17395582, 16858409, 15210743, 15210742 The latter involves TNF (tumor necrosis factor) receptor-associating factor 3 (TRAF3) (17) and the protein kinase, I{kappa}B kinase-i (IKK-i ({epsilon})) or TANK-binding kinase-1 (TBK-1) (18, 19), which is responsible for the activation of IRF-3 and -7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c32 : 1
stoichiometry:c34 : 1
stoichiometry:c36 : 1
stoichiometry:c38 : 1
m38*m36*m37*0.1
nodelay
--
0
PMID: 17395582, 16858409, 15210743, 15210742 The latter involves TNF (tumor necrosis factor) receptor-associating factor 3 (TRAF3) (17) and the protein kinase, I{kappa}B kinase-i (IKK-i ({epsilon})) or TANK-binding kinase-1 (TBK-1) (18, 19), which is responsible for the activation of IRF-3 and -7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c39 : 1
stoichiometry:c47 : 1
stoichiometry:c40 : 1
m41*m40*0.1
nodelay
--
0
PMID: 17395582, 16858409, 15210743, 15210742 The latter involves TNF (tumor necrosis factor) receptor-associating factor 3 (TRAF3) (17) and the protein kinase, I{kappa}B kinase-i (IKK-i ({epsilon})) or TANK-binding kinase-1 (TBK-1) (18, 19), which is responsible for the activation of IRF-3 and -7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c41 : 1
stoichiometry:c49 : 1
stoichiometry:c42 : 1
m41*m39*0.1
nodelay
--
0
PMID: 17395582, 16858409, 15210743, 15210742 The latter involves TNF (tumor necrosis factor) receptor-associating factor 3 (TRAF3) (17) and the protein kinase, I{kappa}B kinase-i (IKK-i ({epsilon})) or TANK-binding kinase-1 (TBK-1) (18, 19), which is responsible for the activation of IRF-3 and -7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c50 : 1
stoichiometry:c44 : 1
m42*m39*0.1
nodelay
--
0
PMID: 17395582, 16858409, 15210743, 15210742 The latter involves TNF (tumor necrosis factor) receptor-associating factor 3 (TRAF3) (17) and the protein kinase, I{kappa}B kinase-i (IKK-i ({epsilon})) or TANK-binding kinase-1 (TBK-1) (18, 19), which is responsible for the activation of IRF-3 and -7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c48 : 1
stoichiometry:c46 : 1
m42*m40*0.1
nodelay
--
0
PMID: 17395582, 16858409, 15210743, 15210742 The latter involves TNF (tumor necrosis factor) receptor-associating factor 3 (TRAF3) (17) and the protein kinase, I{kappa}B kinase-i (IKK-i ({epsilon})) or TANK-binding kinase-1 (TBK-1) (18, 19), which is responsible for the activation of IRF-3 and -7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c55 : 1
stoichiometry:c52 : 1
m45*m33*0.1
nodelay
--
0
PMID: 17395582 The signal is branched at IPS-1, resulting in the activation of NF-kappaB and IRF-3 and -7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c56 : 1
stoichiometry:c54 : 1
m45*m30*0.1
nodelay
--
0
PMID: 17395582 The signal is branched at IPS-1, resulting in the activation of NF-kappaB and IRF-3 and -7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c59 : 1
stoichiometry:c58 : 1
m47*m46*0.1
nodelay
--
0
PMID: 17395582 The signal is branched at IPS-1, resulting in the activation of NF-kappaB and IRF-3 and -7.
p2
p2
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m12*m5*0.1
nodelay
--
0
PMID: 17395582 The virus-specific RNA species, dsRNA or 5'-triphosphate ssRNA, specifically binds to RIG-I through its RNA binding domain. PMID: 17395582, 17190814 RNA binding requires intact helicase and C-terminal autorepression domains.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c64 : 1
stoichiometry:c62 : 1
m43*0.1
nodelay
--
0
PMID: 17395582, 16116171, 16210631, 17020950 LGP2 lacks CARD, suggesting that this helicase is incapable of transmitting a positive signal. Overexpression of LGP2 in cell culture results in the dominant inhibition of virus-induced activation of IFN genes, suggesting its role as a negative regulator; however, its role in vivo is not established. PMID: 17395582 Analyses of RIG-I?/? fibroblasts and conventional dendritic cells (cDCs) showed that RIG-I is essential in Newcastle disease virus (NDV)-induced IFN production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c65 : 1
stoichiometry:c63 : 1
m44*0.1
nodelay
--
0
PMID: 17395582, 16116171, 16210631, 17020950 LGP2 lacks CARD, suggesting that this helicase is incapable of transmitting a positive signal. Overexpression of LGP2 in cell culture results in the dominant inhibition of virus-induced activation of IFN genes, suggesting its role as a negative regulator; however, its role in vivo is not established. PMID: 17395582 Analyses of RIG-I?/? fibroblasts and conventional dendritic cells (cDCs) showed that RIG-I is essential in Newcastle disease virus (NDV)-induced IFN production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c68 : 1
stoichiometry:c70 : 1
stoichiometry:c69 : 1
m64*m68*0.1
nodelay
--
0
PMID: 17395582, 15585605, 16932750 pDCs adopt a distinct signaling cascade to produce high levels of IFN-alpha and sense viral infection by TLR7/8 and TLR9, activating signaling cascades MyD88, IRAK1/4, TRAF3/6, IKK-alpha, and IRF-7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c71 : 1
stoichiometry:c67 : 1
m64*m70*0.1
nodelay
--
0
PMID: 17395582, 15585605, 16932750 pDCs adopt a distinct signaling cascade to produce high levels of IFN-alpha and sense viral infection by TLR7/8 and TLR9, activating signaling cascades MyD88, IRAK1/4, TRAF3/6, IKK-alpha, and IRF-7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c79 : 1
stoichiometry:c78 : 1
m77*m74*0.1
nodelay
--
0
PMID: 17395582, 15585605, 16932750 pDCs adopt a distinct signaling cascade to produce high levels of IFN-alpha and sense viral infection by TLR7/8 and TLR9, activating signaling cascades MyD88, IRAK1/4, TRAF3/6, IKK-alpha, and IRF-7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c74 : 1
stoichiometry:c73 : 1
m73*m69*0.1
nodelay
--
0
PMID: 17395582, 15585605, 16932750 pDCs adopt a distinct signaling cascade to produce high levels of IFN-alpha and sense viral infection by TLR7/8 and TLR9, activating signaling cascades MyD88, IRAK1/4, TRAF3/6, IKK-alpha, and IRF-7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c80 : 1
stoichiometry:c76 : 1
m75*m74*0.1
nodelay
--
0
PMID: 17395582, 15585605, 16932750 pDCs adopt a distinct signaling cascade to produce high levels of IFN-alpha and sense viral infection by TLR7/8 and TLR9, activating signaling cascades MyD88, IRAK1/4, TRAF3/6, IKK-alpha, and IRF-7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c81 : 1
stoichiometry:c85 : 1
stoichiometry:c82 : 1
m79*m76*0.1
nodelay
--
0
PMID: 17395582, 15585605, 16932750 pDCs adopt a distinct signaling cascade to produce high levels of IFN-alpha and sense viral infection by TLR7/8 and TLR9, activating signaling cascades MyD88, IRAK1/4, TRAF3/6, IKK-alpha, and IRF-7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c86 : 1
stoichiometry:c84 : 1
m79*m78*0.1
nodelay
--
0
PMID: 17395582, 15585605, 16932750 pDCs adopt a distinct signaling cascade to produce high levels of IFN-alpha and sense viral infection by TLR7/8 and TLR9, activating signaling cascades MyD88, IRAK1/4, TRAF3/6, IKK-alpha, and IRF-7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c89 : 1
stoichiometry:c88 : 1
m42*m80*0.1
nodelay
--
0
PMID: 17395582, 15585605, 16932750 pDCs adopt a distinct signaling cascade to produce high levels of IFN-alpha and sense viral infection by TLR7/8 and TLR9, activating signaling cascades MyD88, IRAK1/4, TRAF3/6, IKK-alpha, and IRF-7.
p3
p3
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m5*m14*0.1
nodelay
--
0
PMID: 17395582, 15208624, 15708988 RIG-I exhibits strong double-stranded RNA (dsRNA) binding activity in vitro. RIG-I selectively binds with poly(rI:rC), poly(rA:rU), and 5'- and 3'-untranslated regions of hepatitis C virus genomic RNA (which are predicted to form a secondary structure) but not with dsDNA, poly(rA), or yeast tRNA.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c91 : 1
stoichiometry:c92 : 1
m6*m71*0.1
nodelay
--
0
PMID: 17395582, 15585605 It has been known that dsRNA activates TLR3 in endosome and signals through TIR domain-containing adaptor inducing IFN-beta (TRIF)/TIR-containing adaptor molecule-1 (TICAM1) resulting in the activation of kinases (TBK-1 or IKK-i) and transcription factors (IRF-3 and -7 and NF-kappaB).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c94 : 1
stoichiometry:c95 : 1
m72*m81*0.1
nodelay
--
0
PMID: 17395582, 15585605 It has been known that dsRNA activates TLR3 in endosome and signals through TIR domain-containing adaptor inducing IFN-beta (TRIF)/TIR-containing adaptor molecule-1 (TICAM1) resulting in the activation of kinases (TBK-1 or IKK-i) and transcription factors (IRF-3 and -7 and NF-kappaB).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c96 : 1
stoichiometry:c98 : 1
stoichiometry:c97 : 1
m83*m82*0.1
nodelay
--
0
PMID: 17395582, 15585605 It has been known that dsRNA activates TLR3 in endosome and signals through TIR domain-containing adaptor inducing IFN-beta (TRIF)/TIR-containing adaptor molecule-1 (TICAM1) resulting in the activation of kinases (TBK-1 or IKK-i) and transcription factors (IRF-3 and -7 and NF-kappaB).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c104 : 1
stoichiometry:c100 : 1
m41*m84*0.1
nodelay
--
0
PMID: 17395582, 15585605 It has been known that dsRNA activates TLR3 in endosome and signals through TIR domain-containing adaptor inducing IFN-beta (TRIF)/TIR-containing adaptor molecule-1 (TICAM1) resulting in the activation of kinases (TBK-1 or IKK-i) and transcription factors (IRF-3 and -7 and NF-kappaB).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c103 : 1
stoichiometry:c102 : 1
m42*m84*0.1
nodelay
--
0
PMID: 17395582, 15585605 It has been known that dsRNA activates TLR3 in endosome and signals through TIR domain-containing adaptor inducing IFN-beta (TRIF)/TIR-containing adaptor molecule-1 (TICAM1) resulting in the activation of kinases (TBK-1 or IKK-i) and transcription factors (IRF-3 and -7 and NF-kappaB).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c105 : 1
stoichiometry:c107 : 1
stoichiometry:c106 : 1
m47*m82*0.1
nodelay
--
0
PMID: 17395582, 15585605 It has been known that dsRNA activates TLR3 in endosome and signals through TIR domain-containing adaptor inducing IFN-beta (TRIF)/TIR-containing adaptor molecule-1 (TICAM1) resulting in the activation of kinases (TBK-1 or IKK-i) and transcription factors (IRF-3 and -7 and NF-kappaB).
p36
p36
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c108 : 1
stoichiometry:c109 : 1
stoichiometry:c110 : 1
m14*m27*0.1
nodelay
--
0
PMID: 17395582 When poly(rI:rC) is injected into mice intravenously, IFN-beta is strictly produced in a MDA5-dependent manner (below), but the TLR-TRIF pathway is dispensable.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c111 : 1
stoichiometry:c112 : 1
m85*0.1
nodelay
--
0
PMID: 17395582 When poly(rI:rC) is injected into mice intravenously, IFN-beta is strictly produced in a MDA5-dependent manner (below), but the TLR-TRIF pathway is dispensable.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c114 : 1
stoichiometry:c113 : 1
m82*0.1
nodelay
--
0
PMID: 17395582, 16625202 However, production of IL-8 and IL-12 p40 requires TRIF in addition to MDA5; IL-12 p40 is particularly largely TRIF-dependent.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c117 : 1
stoichiometry:c115 : 1
m82*0.1
nodelay
--
0
PMID: 17395582, 16625202 However, production of IL-8 and IL-12 p40 requires TRIF in addition to MDA5; IL-12 p40 is particularly largely TRIF-dependent.
p4
p4
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m5*m15*0.1
nodelay
--
0
PMID: 17395582, 15208624, 15708988 RIG-I exhibits strong double-stranded RNA (dsRNA) binding activity in vitro. RIG-I selectively binds with poly(rI:rC), poly(rA:rU), and 5'- and 3'-untranslated regions of hepatitis C virus genomic RNA (which are predicted to form a secondary structure) but not with dsDNA, poly(rA), or yeast tRNA.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c118 : 1
stoichiometry:c120 : 1
stoichiometry:c119 : 1
m29*m89*0.1
nodelay
--
0
PMID: 17395582, 16125763, 16585524, 16731946 NS3/4A of hepatitis C virus inactivates IPS-1 by its protease activity.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c125 : 1
m85*0.1
nodelay
--
0
PMID: 17395582, 16625202 However, production of IL-8 and IL-12 p40 requires TRIF in addition to MDA5; IL-12 p40 is particularly largely TRIF-dependent.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c14 : 1
stoichiometry:c18 : 1
stoichiometry:c122 : 1
stoichiometry:c15 : 1
m29*m32*0.1
nodelay
--
0
PMID: 17395582, 16127453, 16125763, 16153868 This association and ATP binding to the helicase domain change RIG-I conformation to release CARD for relaying signaling to the downstream molecule (another CARD-containing molecule, IPS-1 (alternatively termed MAVS, VISA, and Cardif)). PMID: 17395582 Table2
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c16 : 1
stoichiometry:c17 : 1
m11*m31*0.1
nodelay
--
0
PMID: 17395582, 16127453, 16125763, 16153868 This association and ATP binding to the helicase domain change RIG-I conformation to release CARD for relaying signaling to the downstream molecule (another CARD-containing molecule, IPS-1 (alternatively termed MAVS, VISA, and Cardif)). PMID: 17395582 Lys-270 is supposed to be a critical motif for ATP binding within the helicase domain, and in the case of other DExH/D helicases, this motif is crucial for its helicase (unwinding dsRNA) activity.
p7
p7
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c124 : 1
stoichiometry:c21 : 1
m6*m27*0.1
nodelay
--
0
PMID: 17395582, 16785313, 16713980 MDA5 and RIG-I, which sense a distinct set of viruses (below), commonly transmit signals to IPS-1; thus IPS-1?/? fibroblasts are unresponsive to either set of viruses. PMID: 17395582 Table2
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m28*m29*0.1
nodelay
--
0
PMID: 17395582, 16785313, 16713980 MDA5 and RIG-I, which sense a distinct set of viruses (below), commonly transmit signals to IPS-1; thus IPS-1?/? fibroblasts are unresponsive to either set of viruses.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c27 : 1
stoichiometry:c29 : 1
m34*m33*0.1
nodelay
--
0
PMID: 17395582, 16858409, 15210743, 15210742 The latter involves TNF (tumor necrosis factor) receptor-associating factor 3 (TRAF3) (17) and the protein kinase, I{kappa}B kinase-i (IKK-i ({epsilon})) or TANK-binding kinase-1 (TBK-1) (18, 19), which is responsible for the activation of IRF-3 and -7.
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--